Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Large Volume Parenteral Market, By Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ml-250 ml, 250 ml-500 ml, 500 ml-1000 ml, 1000 ml-2000 ml, 2000 ml and more), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.
Large Volume Parenteral Market Analysis and Size
The global large volume parenteral market is rising steadily due to regulatory requirements. Growing R&D activities is considerably driving the global large volume parenteral market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings to acquire a competitive advantage.
Data Bridge Market Research analyses that the global large volume parenteral market which was USD 9,200.00 Million in 2022, would rocket up to USD 14,998.71 Million by 2030 and is expected to undergo a CAGR of 6.3% during the forecast period. "Soft bag" dominates the type segment of the global large volume parenteral market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Large Volume Parenteral Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ml-250 ml, 250 ml-500 ml, 500 ml-1000 ml, 1000 ml-2000 ml, 2000 ml, and more), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa |
|
Market Players Covered |
Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (U.S.), Otsuka America Pharmaceutical, Inc. (U.S.), Sichuan KELUN PHARMACEUTICAL Co., Ltd.(China), Cook Pharmica LLC.(U.S.), Thermo Fisher Scientific Inc. (U.S.), BAG Health Care GmbH (Germany), Baxter (U.S.), WOCKHARDT (India), Southwest Pharmaceutical Co. Ltd. (China) |
|
Market Opportunities |
|
Market Definition
The global Large Volume Parenteral (LVP) market is for intravenous solutions or fluids administered in large volumes to patients. LVPs are sterile solutions typically provided in containers such as bottles or bags. These solutions are used for various medical purposes, including fluid and electrolyte replacement, nutritional support, medication administration, and other therapeutic interventions.
Global Large Volume Parenteral Market Dynamics
Drivers
- Increasing prevalence of chronic diseases
The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has led to a growing demand for LVP products, often used for administering medications in these conditions.
- Technological advancements
The development of innovative manufacturing techniques, such as aseptic filling systems and advanced filtration technologies, has improved the safety, sterility, and efficiency of LVP production. These technological advancements have boosted market growth.
Opportunities
-
Expansion of home healthcare
The trend towards home-based healthcare services provides opportunities for the LVP market. Patients receiving long-term intravenous therapies may opt for home healthcare, increasing the demand for LVP products outside traditional hospital settings.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
- High cost associated with the product manufacturing
The high cost associated with product manufacturing is expected to obstruct market growth. Also, the supply chain industry disruption can challenge the market's growth. In addition, the lack of a favorable reimbursement scenario, technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This global large volume parenteral report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global large volume parenteral market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2021, Baxter International Inc. received U.S. Food and Drug Administration (FDA) approval for its premixed, ready-to-use 0.9% Sodium Chloride Injection Bags. This product launch aimed to provide healthcare professionals with a convenient option for intravenous fluid therapy.
- In 2020, Pfizer Inc. launched a new presentation of its Liposyn III 30% (Intravenous Fat Emulsion) product. The new presentation offered a larger container size, allowing for easier handling and administration in critical care settings.
Global Large Volume Parenteral Market Scope
The global large volume parenteral market is segmented based on type, volume, application, end-users, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
Volume
- 100 ml-250 ml
- 250 ml-500 ml
- 500 ml-1000 ml
- 1000 ml-2000 ml
- 2000 ml and more
Application
- Therapeutic Injections
- Fluid Balance Injections
- Nutritious Injections
End-Users
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Large Volume Parenteral Market Regional Analysis/Insights
Global large volume parenteral market is analyzed, and market size insights and trends are provided by type, volume, application, end-users, and distribution channel, as referenced above.
The countries covered in the global large volume parenteral market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, and rest of Middle East and Africa.
North America dominates the market due to rising healthcare costs, increased R&D, and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favorable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The large volume parenteral market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for large volume parenteral market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the the market. The data is available for historic period 2015-2020.
Competitive Landscape and Large Volume Parenteral Market Share Analysis
The large volume parenteral market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the large volume parenteral market are:
- Teva Pharmaceutical Industries Ltd. (Israel)
- Pfizer Inc. (U.S.)
- Otsuka America Pharmaceutical, Inc. (U.S.)
- Sichuan KELUN PHARMACEUTICAL Co., Ltd.(China)
- Cook Pharmica LLC. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- BAG Health Care GmbH (Germany)
- Baxter (U.S.)
- WOCKHARDT (India)
- Southwest Pharmaceutical Co. Ltd. (China)
SKU-
